EO
Eric Ostertag
Director

Eric Ostertag insider trades: Poseida Therapeutics (PSTX) stock buys and sales

Director, Poseida Therapeutics Last trade Aug 8, 2022 24 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
16
Open-market trades
since 2021
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eric reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 8, 2022PSTX↑ Buy$500K
Aug 3, 2022PSTX↓ Sell$593K
Nov 8, 2021PSTX↓ Sell$134K
Oct 1, 2021PSTX↓ Sell$141K
Sep 20, 2021PSTX↓ Sell$160K
Sep 14, 2021PSTX↓ Sell$163K
Sep 2, 2021PSTX↓ Sell$944K
Aug 3, 2021PSTX↓ Sell$271K
Jul 2, 2021PSTX↓ Sell$446K
Jun 2, 2021PSTX↓ Sell$694K
May 4, 2021PSTX↓ Sell$469K
Apr 5, 2021PSTX↓ Sell$1.1M
Mar 2, 2021PSTX↓ Sell$1.3M
Feb 16, 2021PSTX↓ Sell$1.3M
Feb 10, 2021PSTX↓ Sell$124K
Jan 21, 2021PSTX↓ Sell$45K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Eric Ostertag's insider trades

Eric Ostertag is a director at Poseida Therapeutics (PSTX). Since Jan 21, 2021, Eric has reported 1 open-market purchase worth $500K and 15 sales worth $8.0M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (6 filings), grants and awards (2 filings), shares withheld for taxes (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PSTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.